Amend

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Thursday, October 21, 2021
Biotechnology, Pharmaceutical, Health, Medication, Security (finance), Cyprus Securities and Exchange Commission, Patient, Private Securities Litigation Reform Act, Amend, Human resources, Arena Pharmaceuticals, Senior, Financial compensation, RSU, Board, Professional Football Compensation Committee, Nasdaq, Employment, Management

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the Compensation Committee of its Board of Directors granted inducement stock options and inducement restricted stock units ("RSUs") to new employees.

Key Points: 
  • Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the Compensation Committee of its Board of Directors granted inducement stock options and inducement restricted stock units ("RSUs") to new employees.
  • The inducement stock options and inducement RSUs are subject to the terms and conditions of Arena's Amended and Restated 2021 Long-Term Incentive Plan.
  • ARENA Pharmaceuticals is a team with a singular purpose deliver important medicines to patients.
  • Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

Entrée Resources Files Amended Technical Report for its Interest in the Entrée/Oyu Tolgoi Joint Venture Property

Retrieved on: 
Thursday, October 21, 2021
PEA, Budget, Canadian Securities Administrators, Nature, Disclosure, COVID-19, Health, Accident, IFRS, NPV, Tax, Metal, Heads of Agreement (1981), Sandstorm Gold, Transport, Insurance, Private Securities Litigation Reform Act, Panel, Silver, Risk, Company, News, Video news release, Water, Statistics, Mineral, Industry, Resource management, SEDAR, Amend, Conversation, Phrase, Environment, Gold, Metallurgy, Hugo, Legislation, AG, ASIC, Mining, HNE, Mineral resource classification, National instrument, Copper, Reserved cases, Person, Review, MT, Treaty of friendship and alliance between the Government of Mongolia and Tibet, National Instrument 43-101, Economics, Rio Tinto, Coronavirus, Lithium, Animal, Cryptocurrency, Risk management

Mineral Reserves in the 2021 Reserve Case, and Mineral Resources in the 2021 PEA mine plan are reported on a 100% basis.

Key Points: 
  • Mineral Reserves in the 2021 Reserve Case, and Mineral Resources in the 2021 PEA mine plan are reported on a 100% basis.
  • Attributable Entre/Oyu Tolgoi JV production begins in 2031 and ramps up to stable production in 2043.
  • Entre Resources Ltd. is a well-funded Canadian mining company with a unique carried joint venture interest on a significant portion of one of the world's largest copper-gold projects the Oyu Tolgoi project in Mongolia.
  • Entre has a 20% or 30% carried participating interest in the Entre/Oyu Tolgoi JV, depending on the depth of mineralization.

Kirkland Lake Gold Announces Filing of Amended and Restated Detour Lake Mine Technical Report

Retrieved on: 
Wednesday, October 20, 2021
Report, Virus, TSX, Technical report, Resource management, Security (finance), GLOBE, Ventilation, Industry, KLA, National instrument, Safety, ASX, Risk, COVID-19, Disclosure, Canadian Institute of Mining, Metallurgy and Petroleum, EDGAR, SEDAR, Information technology, Knowledge, COVID19, SEC, Investment, AIF, Acquisition, Regulation, Ministry of Oil and Mineral Reserves (Syria), News, U.S. Securities and Exchange Commission, Metallurgy, Kirkland Lake Gold, Weather, Insurance, Health, Engineering, Gold, Mining, NYSE, Water, Infection, Amend, Rehabilitation, NI, Maintenance, Company, Risk management

As with the original technical report filed on October 15, 2021, the Amended Report is entitled, Detour Lake Operation, Ontario, Canada, NI 43-101 Report and is effective as of July 26, 2021.

Key Points: 
  • As with the original technical report filed on October 15, 2021, the Amended Report is entitled, Detour Lake Operation, Ontario, Canada, NI 43-101 Report and is effective as of July 26, 2021.
  • There are no material differences between the Amended Report and the original technical report and there are no differences in the Mid-Year 2021 Mineral Resource Estimates.
  • The Amended Report includes revisions to address formatting issues affecting the presentation of Tables 1-3, 1-4, 14-23 and 14-24.
  • About Kirkland Lake Gold Ltd.
    Kirkland Lake Gold Ltd. is a senior gold producer operating in Canada and Australia that is targeting 1,300,000 1,400,000 ounces of production in 2021.

GetSwift Technologies Limited files Audited Annual Consolidated Financial Statements, MD&A, and Annual Information Form for the fiscal year ended June 30, 2021

Retrieved on: 
Saturday, October 16, 2021
Logistics, Supply Chain Management, Data Management, Transport, Technology, Software, Risk, CFO, Technology, British Columbia Securities Commission, Cth, Time, Corporation, NEO, Private sector, Intention, Pandemic, NEO Exchange, Compliance, LDA, Automation, Data management, AUD, AIF, News, Amend, SEDAR, Nature, Contract, Federal court, Calendar, CEO, Review, Software as a service, FLI, Federal Court of Australia, CTO, Commission, Pressure, COVID-19, Animal, Pharmaceutical industry, Bank, Audit, Risk management

Cash used from operating activities was $14.6 million, a reduction of 16% over fiscal year end 2019.

Key Points: 
  • Cash used from operating activities was $14.6 million, a reduction of 16% over fiscal year end 2019.
  • Subsequent to year-end, the Corporation placed AUD $500,000 into escrow with external legal counsel in relation to the proposed settlement.
  • The information provided in this news release should be read in conjunction with the 2021 Annual Financial Statements.
  • The Corporation will review its financial results for the fiscal year ended June 30, 2021 and discuss the Corporations business initiatives during a business update conference call.

JX Luxventure Limited Announces Changes of its Corporate Name and its Trading Symbol

Retrieved on: 
Wednesday, October 13, 2021
Person, Private Securities Litigation Reform Act, Company, NASDAQ, Capricorn (A Brand New Name), Amend, Corporation, Nasdaq, Article, Tourism, LLL, U.S. Securities and Exchange Commission, Amendment, Security (finance), Registrar, Name, Marshall Islands, Republic, Airline

HAIKOU, China, Oct. 13, 2021 /PRNewswire/ -- JX Luxventure Limited (NASDAQ: LLL) (the "Company"), a company engaged in casual menswear, cross-border merchandise, airfare and tourism businessannounced today that its corporate name and trading symbol changes are complete.

Key Points: 
  • HAIKOU, China, Oct. 13, 2021 /PRNewswire/ -- JX Luxventure Limited (NASDAQ: LLL) (the "Company"), a company engaged in casual menswear, cross-border merchandise, airfare and tourism businessannounced today that its corporate name and trading symbol changes are complete.
  • The Company notified Nasdaq Capital Market of the Name Change and the change of its trading symbol from "KBSF" to "LLL".
  • At the opening of the market today, the Company's common stock will begin trading on the Nasdaq Capital Market under the Company's New Name, JX Luxventure Limited, and its new trading symbol, LLL.
  • This press release may contain certain "forward-looking statements" relating to the business of JX Luxventure Limited, and its subsidiary companies.

Capital Senior Living Sets the Record Straight for Shareholders

Retrieved on: 
Thursday, October 7, 2021
Residential Building & Real Estate, Construction & Property, Seniors, Consumer, Form, Amend, Proxy, Conversational Capital, Board of directors, LTV, SEC, Board, Form S-3, NYSE, AND, Sale, Capital Senior Living, Dynamic currency conversion, Freedom, Company, Twitter, NDA, Special, CSU, ANY, Growth, WHEN, U.S. Securities and Exchange Commission, Communication, Hand, PIPE, Public expenditure, Prospectus, Multimedia, Probability, Annual report, Investment, Pressure, Facebook, Risk, NOT, Letter, AS, THE, Capital, Security (finance), Partner, Compliance, Bank, Cryptocurrency, Internet service provider, Commercial property, Capital Senior Living, Conversant, CAPITAL SENIOR LIVING, CONVERSANT

Capital Senior Living Corporation (Capital Senior Living or the Company) (NYSE: CSU), a leading owner-operator of senior living communities across the United States, today sent a letter to its shareholders setting the record straight around its plans to raise up to $154.8 million through a series of recently amended financing transactions between the Company and Conversant Capital (the Amended Transactions).

Key Points: 
  • Capital Senior Living Corporation (Capital Senior Living or the Company) (NYSE: CSU), a leading owner-operator of senior living communities across the United States, today sent a letter to its shareholders setting the record straight around its plans to raise up to $154.8 million through a series of recently amended financing transactions between the Company and Conversant Capital (the Amended Transactions).
  • The Amended Transactions provide immediate liquidity to address working capital deficits, fund greatly needed capital expenditures, resolve near-term debt maturities, and stabilize the Company.
  • All of Invictus capital would be senior to existing shareholders, and their proposed structure prioritizes payments to them over sustainable investment and growth of the business.
  • Dallas-based Capital Senior Living Corporation is one of the nations leading operators of independent living, assisted living and memory care communities for senior adults.

Nevada Copper Announces Financing Update

Retrieved on: 
Saturday, October 2, 2021
News, Insurance, Review, Failure, Climate change, Nevada Copper Belt Railroad, Phrase, Company, Weather, Mining, Amend, COVID-19, History, Forward-looking statement, Accident, Industry, Audit, Risk management

Nevada Copper disclaims any intent or obligation to update forward-looking statements or information except as required by law.

Key Points: 
  • Nevada Copper disclaims any intent or obligation to update forward-looking statements or information except as required by law.
  • Readers are referred to the additional information regarding Nevada Coppers business contained in Nevada Coppers reports filed with the securities regulatory authorities in Canada.
  • For more information on Nevada Copper and the risks and challenges of its business, investors should review Nevada Coppers filings that are available at www.sedar.com.
  • Nevada Copper provides no assurance that forward-looking statements and information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements or information.

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Friday, October 1, 2021
Heart failure, Muscle weakness, NDA, Employment, Private Securities Litigation Reform Act, Patient, Cyprus Securities and Exchange Commission, LinkedIn, YouTube, Cohort, Cytokinetics, HCM, Twitter, Company, Pharmacology, SAN, Amend, Facebook, ALS, Research, Mechanics, History, Forward-looking statement, Hypertrophic cardiomyopathy, Industry, Multisystemic smooth muscle dysfunction syndrome, GLOBE, Pharmaceutical industry, Public relations

Cytokinetics is also developing aficamten, a next-generation cardiac myosin inhibitor, for the potential treatment of hypertrophic cardiomyopathies (HCM).

Key Points: 
  • Cytokinetics is also developing aficamten, a next-generation cardiac myosin inhibitor, for the potential treatment of hypertrophic cardiomyopathies (HCM).
  • Cytokinetics expects to start a Phase 3 clinical trial of aficamten in patients with obstructive HCM in Q4 2021.
  • Cytokinetics is also developing reldesemtiv, a fast skeletal muscle troponin activator, currently the subject of COURAGE-ALS, a Phase 3 clinical trial in patients with ALS.
  • Examples of such statements include, but are not limited to, statements relating toCytokinetics'and its partners' research and development activities of Cytokinetics product candidates.

Acreage Holdings Acquires Cultivation, Processing, and Retail Operations in Ohio

Retrieved on: 
Friday, October 1, 2021
OH, News, CBD, Innocence, Botany, OTC, High Street, Sale, Acreage Holdings, Mission statement, Canada Business Corporations Act, Class, CSE, SEC, Phrase, Marketing, Trauma trigger, Acquisition, Legislation, LLC, Growth, SEDAR, Amend, Capsule, Forward-looking statement, EDGAR, State, GLOBE, Drug, Security (finance)

Upon completion of these acquisitions, Acreage will subsequently consolidate the results of Greenleaf into its consolidated financial statements.

Key Points: 
  • Upon completion of these acquisitions, Acreage will subsequently consolidate the results of Greenleaf into its consolidated financial statements.
  • Greenleafs retail operations in Ohio include 5 operational dispensaries, branded The Botanist, in Akron, Canton, Cleveland, Columbus and Wickliffe.
  • The closing of our acquisition of Greenleafs operations in Ohio will significantly strengthen both our operating asset base and our long-term financial performance, said Peter Caldini, Chief Executive Officer of Acreage.
  • Since its founding in 2011, Acreage has focused on building and scaling operations to create a seamless, consumer-focused, branded experience.

Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Friday, September 17, 2021
Biotechnology, Pharmaceutical, Health, Private Securities Litigation Reform Act, Amend, Securities and Exchange Commission (Nigeria), Arena Pharmaceuticals, Patient, Medication, Financial compensation, RSU, Nasdaq, Employment, Board, Security (finance)

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the Compensation Committee of its Board of Directors granted to 20 new employees inducement stock options to purchase an aggregate of 33,340 shares of its common stock and 15,655 inducement restricted stock units ("RSUs").

Key Points: 
  • Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the Compensation Committee of its Board of Directors granted to 20 new employees inducement stock options to purchase an aggregate of 33,340 shares of its common stock and 15,655 inducement restricted stock units ("RSUs").
  • The inducement stock options and RSUs have a grant date and vesting commencement date of September 15, 2021 and were granted as inducements material to the new employees entering employment with Arena in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The inducement stock options and inducement RSUs are subject to the terms and conditions of Arena's Amended and Restated 2021 Long-Term Incentive Plan.
  • ARENA Pharmaceuticals is a team with a singular purpose deliver important medicines to patients.